PARK2 Polyclonal Antibody

The precise function of PARK2 is unknown; however, the encoded protein is a component of a multiprotein E3 ubiquitin ligase complex that mediates the targeting of substrate proteins for proteasomal degradation. Mutations in PARK2 are known to cause Parkinson disease and autosomal recessive juvenile Parkinson disease. Alternative splicing of this gene produces multiple transcript variants encoding distinct isoforms. Additional splice variants of this gene have been described but currently lack transcript support.

The PARK2 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of PARK2 protein expression. This antibody is produced using advanced techniques, ensuring its high affinity and specificity towards PARK2. With its exceptional performance, this antibody is suitable for various applications, including Western blotting, immunohistochemistry, and immunofluorescence. The PARK2 Polyclonal Antibody exhibits minimal cross-reactivity with other proteins, guaranteeing accurate and reliable results. Its superior sensitivity allows for the detection of even low levels of PARK2 protein, making it an invaluable asset for researchers and scientists studying Parkinson's disease and related disorders. Additionally, this antibody is provided in a convenient format, allowing for easy handling and storage. Trust in the PARK2 Polyclonal Antibody to provide precise and reproducible results, enabling groundbreaking discoveries in the field of neurodegenerative diseases.